http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018049918-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a0eaedc074614412a2e8973294455176
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-0612
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M29-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00727
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M29-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
filingDate 2017-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81a56f7dc3d534acaf7184c1a2016662
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_558d8c0c5ee60d9b269fc7ebc2866726
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba1d9c3343dc3e431260e6ac6b4cf5da
publicationDate 2018-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2018049918-A1
titleOfInvention Sub-cutaneous medicinal dosage delivery implant system
abstract A subcutaneous implant system is applicable in a variety of surgical procedures and includes a balloon shaped implant formed from a bioresorbable material and is capable of assuming deflated and inflated configurations. The balloon shaped implant is inserted, in its deflated configuration, into the patient's body, and subsequently is inflated by filling the balloon shaped implant with a medicinal agent. The balloon shaped implant filled with the medicinal agent remains in the body and permits a steady-state release of the medicinal agent therefrom. The balloon shaped implant has a wall which may be formed from either a solid material which is impermeable to the medicinal agent, or a porous material. The medicinal agent egresses from the interior of the balloon shaped member in a controlled manner provided by a mechanism which may include a permeable membrane, a check valve, a flap valve, openings in a porous wall of the balloon shaped member, and combinations thereof. Upon the medicinal agent has been depleted, the balloon shaped implant is “naturally removed” from the body through bio-dissolution in the patient's body.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11679180-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108524095-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020163850-A1
priorityDate 2016-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005245906-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID20604
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO46688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399670
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24797
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01168
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP60041
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396279
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP61278
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9PRR0
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419560844
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID443006
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16129706
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280932
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCEDK97673
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP60042
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP61279
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403993
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422601313
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP33094
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16157882
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19209
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16161315

Total number of triples: 44.